Bronchiolitis obliterans (BO) treatment with collagen with collagen type V and corticoid by nasal-drop in Balb-c mice (BM)

A. L. Garippo, W. R. Teodoro, E. R. Parra, A. P. Velosa, N. H. Yoshinari, V. L. Capelozzi (Sao Paulo, Brazil)

Source: Annual Congress 2005 - The injured lung: pathogenesis and interventions
Session: The injured lung: pathogenesis and interventions
Session type: Poster Discussion
Number: 4657
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. L. Garippo, W. R. Teodoro, E. R. Parra, A. P. Velosa, N. H. Yoshinari, V. L. Capelozzi (Sao Paulo, Brazil). Bronchiolitis obliterans (BO) treatment with collagen with collagen type V and corticoid by nasal-drop in Balb-c mice (BM). Eur Respir J 2005; 26: Suppl. 49, 4657

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchiolitis obliterans (BO) in mice lung: a simple model by nasal-drop
Source: Eur Respir J 2005; 26: Suppl. 49, 732s
Year: 2005

Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats
Source: Eur Respir J 2007; 30: Suppl. 51, 517s
Year: 2007

Towards a model of bronchiolitis obliterans syndrome in single lung transplanted mice
Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Year: 2010


Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome
Source: Eur Respir J, 57 (5) 2001416; 10.1183/13993003.01416-2020
Year: 2021



Prevention of bronchiolitis obliterans in mice lung by tipo V collagen-induced nasal tolerance
Source: Eur Respir J 2004; 24: Suppl. 48, 103s
Year: 2004

Bronchiolitis obliterans syndrome (BOS) after bone marrow transplantation (BMT) in childhood
Source: Eur Respir J 2003; 22: Suppl. 45, 144s
Year: 2003

Development of bronchiolitis obliterans (BO) using different cyclosporine A based immunosuppressive regimens in both genders in rat trachea grafts
Source: Eur Respir J 2006; 28: Suppl. 50, 779s
Year: 2006

The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007


Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19
Year: 2004

Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011


Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet?
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55
Year: 2004

Do nitrites (NO2) and nitrates (NO3) have a role in the development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008

Mild course of bronchiolitis obliterans (OB) in children
Source: Eur Respir J 2004; 24: Suppl. 48, 258s
Year: 2004

Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004

Azithromycin in bronchiolitis obliterans (BO) and BO organizing pneumonia complicating bone marrow transplantation
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Introduction: new therapeutic approaches to bronchiolitis obliterans
Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation
Year: 2005

Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS)
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018

Comparison of the clinical features of lung cancer in chronic hypersensitivity pneumonitis (CHP) and in collagen vascular disease related interstitial pneumonitis (CVD-IP)
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1
Year: 2004

Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004